Literature DB >> 22367772

Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.

Rebecca L Elstrom, Peter Martin, Sandra Hurtado Rua, Tsiporah B Shore, Richard R Furman, Jia Ruan, Roger N Pearse, Morton Coleman, Tomer Mark, John P Leonard, Usama Gergis.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22367772     DOI： 10.1002/ajh.23108

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  12 in total

Review 1.  High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Authors:  Tanya M Wildes; Amanda Cashen
Journal:  J Geriatr Oncol       Date:  2015-08-10       Impact factor: 3.599

2.  High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.

Authors:  E Schorb; C P Fox; K Fritsch; L Isbell; A Neubauer; A Tzalavras; R Witherall; S Choquet; O Kuittinen; D De-Silva; K Cwynarski; C Houillier; K Hoang-Xuan; V Touitou; N Cassoux; J-P Marolleau; J Tamburini; R Houot; V Delwail; G Illerhaus; C Soussain; B Kasenda
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

3.  Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.

Authors:  Tanya M Wildes; Derek L Stirewalt; Bruno Medeiros; Arti Hurria
Journal:  J Natl Compr Canc Netw       Date:  2014-01       Impact factor: 11.908

4.  Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT.

Authors:  Robert Pytlík; Blanka Vacková; Eva Konířová; Marie Trnková; Petra Blahovcová; David Pohlreich; Kamila Polgárová; Pavel Klener; Kateřina Benešová; Kateřina Kopečková; Jan Pirnos; Marek Trněný
Journal:  Bone Marrow Transplant       Date:  2020-09-03       Impact factor: 5.483

5.  Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.

Authors:  Lova Sun; Shuli Li; Areej El-Jawahri; Philippe Armand; Bimalangshu R Dey; David C Fisher; Eric D Jacobsen; Caron A Jacobson; Ann S LaCasce; Steven L McAfee; Thomas R Spitzer; Yi-Bin Chen; Zachariah DeFilipp
Journal:  Oncologist       Date:  2017-12-28

6.  Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.

Authors:  Rebecca L Olin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 7.  High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.

Authors:  Oscar B Lahoud; Craig S Sauter; Paul A Hamlin; Parastoo Bahrami Dahi
Journal:  Curr Oncol Rep       Date:  2015-09       Impact factor: 5.075

8.  Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.

Authors:  Pashna N Munshi; Yue Chen; Kwang W Ahn; Farrukh T Awan; Amanda Cashen; Geoffrey Shouse; Mazyar Shadman; Paul Shaughnessy; Joanna Zurko; Frederick L Locke; Aaron M Goodman; Jose C Villaboas Bisneto; Craig Sauter; Mohamad A Kharfan-Dabaja; Gabrielle Meyers; Samantha Jaglowski; Alex Herrera; Mehdi Hamadani
Journal:  Transplant Cell Ther       Date:  2022-05-21

9.  Myeloablative I-131-tositumomab with escalating doses of fludarabine and autologous hematopoietic transplantation for adults age ≥ 60 years with B cell lymphoma.

Authors:  Ajay K Gopal; Ted A Gooley; Joseph G Rajendran; John M Pagel; Darrell R Fisher; David G Maloney; Frederick R Appelbaum; Ryan D Cassaday; Andrew Shields; Oliver W Press
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-12       Impact factor: 5.742

10.  Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients.

Authors:  Hiroki Hosoi; Shogo Murata; Toshiki Mushino; Shinobu Tamura; Takashi Sonoki
Journal:  Ann Hematol       Date:  2021-01-06       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.